Clinical Trial Update: EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for EC-104 intravitreal implant to treat Diabetic Macular Edema; a Phase 1/2 study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• EC-104 Intravitreal Implant

Snippet

Sponsor: Eclipse Life Sciences, Inc. | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: RECRUITING